Cargando…
It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828818/ https://www.ncbi.nlm.nih.gov/pubmed/31736876 http://dx.doi.org/10.3389/fendo.2019.00738 |
| _version_ | 1783465431919493120 |
|---|---|
| author | Oberle, Megan M. Kelly, Aaron S. |
| author_facet | Oberle, Megan M. Kelly, Aaron S. |
| author_sort | Oberle, Megan M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6828818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68288182019-11-15 It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth Oberle, Megan M. Kelly, Aaron S. Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2019-10-29 /pmc/articles/PMC6828818/ /pubmed/31736876 http://dx.doi.org/10.3389/fendo.2019.00738 Text en Copyright © 2019 Oberle and Kelly. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Endocrinology Oberle, Megan M. Kelly, Aaron S. It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth |
| title | It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth |
| title_full | It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth |
| title_fullStr | It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth |
| title_full_unstemmed | It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth |
| title_short | It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth |
| title_sort | it is time to consider glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes in youth |
| topic | Endocrinology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828818/ https://www.ncbi.nlm.nih.gov/pubmed/31736876 http://dx.doi.org/10.3389/fendo.2019.00738 |
| work_keys_str_mv | AT oberlemeganm itistimetoconsiderglucagonlikepeptide1receptoragonistsforthetreatmentoftype2diabetesinyouth AT kellyaarons itistimetoconsiderglucagonlikepeptide1receptoragonistsforthetreatmentoftype2diabetesinyouth |